Inrab LS 75mg/20mg Capsule SR
Manufacturer
Insight Labz
Salt Composition
Levosulpiride (75mg) + Rabeprazole (20mg)
Key Information
Short Description
Inrab LS 75mg/20mg Capsule SR is a prescription medicine used to treat gastroesophageal reflux disease (acid reflux), intestinal ulcers, and irritable bowel syndrome.
Dosage Form
Capsule SR
Introduction
Inrab LS 75mg/20mg Capsule SR is a combination of two medicines: Levosulpiride and Rabeprazole. It reduces excess acid production in the stomach and prevents the reflux of stomach acid into the food pipe. It is taken with or without food in a dose and duration as advised by the doctor. The dose you are given will depend on your condition and how you respond to the medicine. You should keep taking this medicine for as long as your doctor recommends.
Directions for Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Inrab LS 75mg/20mg Capsule SR is to be taken empty stomach.
Safety Information
Side Effects
The most common side effects are nausea stomach pain diarrhea flatulence constipation headache weakness and flu-like symptoms.
Alcohol Warning
It is unsafe to consume alcohol with Inrab LS 75mg/20mg Capsule SR.
Breastfeeding Warning
Information regarding the use of Inrab LS 75mg/20mg Capsule SR during breastfeeding is not available. Please consult your doctor.
Pregnancy Warning
Inrab LS 75mg/20mg Capsule SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
How it works
Inrab LS 75mg/20mg Capsule SR is a combination of two medicines: Levosulpiride and Rabeprazole.
Quick Tips
Do not consume alcohol while taking Inrab LS 75mg/20mg Capsule SR as it can increase the risk of stomach damage. Long-term use may cause weak or broken bones. Take adequate intake of dietary calcium and vitamin D or their supplements. Do not take Inrab LS 75mg/20mg Capsule SR for longer than prescribed.
Related Medicines
Rablet L Capsules
Veloz L Capsule
Rabemac LS Capsule
Rabonik Plus Capsule SR
Acera-L Capsule SR
Ansuper-Plus Capsule SR
Colosafe-L Capsule SR
Razo-L Capsule
Ravlage-LSR Capsule
Pyrab L 75mg/20mg Capsule SR
Frequently asked questions
What is the recommended time for administering Inrab LS 75mg/20mg Capsule SR?
Take the Inrab LS 75mg/20mg Capsule SR exactly as prescribed by your doctor. It is generally advisable to take one capsule daily on an empty stomach.
What specific situations should be avoided when taking Inrab LS 75mg/20mg Capsule SR?
Avoid use of Inrab LS 75mg/20mg Capsule SR in individuals with known hypersensitivity to any component or excipient of the medicine.
Does the use of Inrab LS 75mg/20mg Capsule SR often cause dizziness?
Yes, some patients taking Inrab LS 75mg/20mg Capsule SR may experience dizziness (feeling faint, weak, unsteady or lightheaded). If you experience this, it's recommended to rest and resume once your symptoms subside.
Does using Inrab LS 75mg/20mg Capsule SR pose an increased risk of fractures?
Some studies indicate that treatment with Inrab LS 75mg/20mg Capsule SR may potentially increase the risk of osteoporosis-related fractures, such as those in the hip, wrist, or spine. This increased risk is more pronounced in patients who take high doses (multiple daily doses and long-term therapy for a year or longer).
Can driving be done safely while taking Inrab LS 75mg/20mg Capsule SR?
Inrab LS 75mg/20mg Capsule SR can cause drowsiness, dizziness, or blurred vision. Therefore, refrain from operating machinery or vehicles until you fully understand the medicine's effects on your body.
What are the storage and disposal instructions for Inrab LS 75mg/20mg Capsule SR?
Store the medication in its original packaging, tightly sealed. Follow the label's instructions regarding storage or discard any unused medication. It is essential not to allow pets, children, or unauthorized individuals to access this medicine.
